The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20214473.
- Also identified by DOI 10.1086/652237.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The time has come for a global commitment to develop new antibacterial drugs. Current data document the impending disaster due to the confluence of decreasing investment in antibacterial drug research and development concomitant with the documented rapid increase in the level of resistance to currently licensed drugs. Despite the good faith efforts of many individuals, professional societies, and governmental agencies, the looming crisis has only worsened over the past decade.
Medical subject headings
- Anti-Bacterial Agents
- Bacterial Infections
- Biomedical Research
- Drug Discovery
- Drug Resistance, Bacterial